The U.S. has ended tariff exemptions for parcel imports, impacting consumers and e-commerce businesses. Learn how this change may lead to higher costs and supply chain challenges as the nation enforces new duty rates.
In a sweeping change, the Trump administration has terminated the de minimis exemption, impacting low-value parcel shipments to the U.S. This move aims to curb tariff evasion and combat the influx of dangerous goods. Retailers like Shein and Temu are scrambling to adapt to the new rules.
The US has ended a crucial tariff exemption that allowed low-cost imports, impacting millions of shipments daily. Experts warn of rising prices and reduced options for American shoppers as businesses scramble to adapt.
The end of the de minimis exemption on small packages is here, leading to potential billions in new fees for consumers. Many postal services are halting shipments to the U.S., causing disruption in online shopping.
Major European parcel companies like DHL and Royal Mail are suspending shipments to the U.S. due to new tariff policies. Discover how these changes might affect your online shopping!
In a dramatic response to the US scrapping tax exemptions on low-import goods, several European countries are halting postal shipments to the US, impacting e-commerce and small businesses.
Walmart has issued a recall for frozen raw shrimp sold in 13 states due to potential radioactive contamination. The FDA detected Cesium-137 in shipments, raising health concerns. Consumers are urged to discard the affected products.
The FDA has issued a warning against consuming certain frozen shrimp sold at Walmart, linked to unsanitary conditions and the detection of radioactive cesium-137 in shipments from the supplier BMS Foods. Although the shrimp never reached the market, officials urge consumers to throw them away or return them.
The fierce rivalry between Apple and Samsung is reigniting as Samsung's recent surge in smartphone shipments challenges Apple's dominance. With innovative foldable devices and changing consumer preferences, is Apple at risk of losing its crown?
In a surprising turn of events, the FDA has allowed Sarepta Therapeutics to resume shipments of its gene therapy, Elevidys, for younger Duchenne muscular dystrophy patients who can walk, despite concerns over previous fatalities.
